EI
TNDM icon

Ellevest Inc’s Tandem Diabetes Care TNDM Stock Holding History

Ellevest Inc’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-64
Closed -$2.6K – 1503
2023
Q1 		$2.6K Sell
64
-125
-66% -$5.17K ﹤0.01% 1389
2022
Q4 		$8.5K Buy
189
+105
+125% +$4.75K ﹤0.01% 1065
2022
Q3 		$4K Sell
84
-5
-6% -$274 ﹤0.01% 1237
2022
Q2 		$5K Buy
89
+50
+128% +$4.11K ﹤0.01% 1028
2022
Q1 		$5K Sell
39
-16
-29% -$1.87K ﹤0.01% 1052
2021
Q4 		$8K Sell
55
-6
-10% -$810 ﹤0.01% 908
2021
Q3 		$7K Buy
+61
New +$6.72K ﹤0.01% 901

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Ellevest Inc's TNDM Position: Q2 2023 in Review

Ellevest Inc sold out of Tandem Diabetes Care (TNDM) in Q2 2023, closing a stake of 64 shares — an estimated $2.6K sold.

Ellevest Inc first reported a position in TNDM in Q3 2021 and held it in 7 quarters. The position peaked at $8.5K in Q4 2022. 247 funds tracked by Wall St. Rank hold TNDM as of Q2 2023.

  • Ellevest Inc reported no remaining Tandem Diabetes Care position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 64 Tandem Diabetes Care shares in Q2 2023, an estimated $2.6K.
  • Ellevest Inc first reported a position in Tandem Diabetes Care in Q3 2021 and held it in 7 quarters.
  • Ellevest Inc's Tandem Diabetes Care position peaked at $8.5K in Q4 2022.
  • 247 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.